Potential factors that can be used to differentiate between interstitial cystitis/painful bladder syndrome and bladder oversensitivity in women

International Journal of Clinical Practice

Volumn 66, Issue 2, 2012, Pages 146-151

  Kuo, Y C ^a   Kuo, Hann Chorng ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHLORIDE;

ADULT; ARTICLE; BLADDER CAPACITY; CONTROLLED STUDY; CYSTALGIA; CYSTOSCOPY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTERSTITIAL CYSTITIS; MAJOR CLINICAL STUDY; NOCTURIA; OVERACTIVE BLADDER; PAIN ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STRESS INCONTINENCE; URINARY FREQUENCY; URINARY URGENCY; URINE RETENTION; URODYNAMICS; VISUAL ANALOG SCALE;

ADULT; CASE-CONTROL STUDIES; CYSTITIS, INTERSTITIAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOWER URINARY TRACT SYMPTOMS; MIDDLE AGED; PAIN MEASUREMENT; POTASSIUM CHLORIDE; PREDICTIVE VALUE OF TESTS; SENSATION; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE; URODYNAMICS;

EID: 84856082200     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02767.x     Document Type: Article

References (22)

1. Yamaguchi O, Marui E, Kakizaki H, et al., Randomised, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder. BJU Int 2007; 100: 579-87. (Pubitemid 47205477)
2. Homma Y, Yoshida M, Seki N, et al., Symptom assessment tool for overactive bladder syndrome-overactive bladder symptom score. Urology 2006; 68: 318-23. (Pubitemid 44175525)
3. Clemens JQ, Bogart LM, Liu K, Pham C, Suttorp M, Berry SH,. Perceptions of 'urgency' in women with interstitial cystitis/bladder pain syndrome or overactive bladder. Neurourol Urodyn 2011; 30: 402-5.
4. Parsons CL,. The role of a leaky epithelium ad potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int 2011; 107: 370-5.
5. Hanno P, Lin A, Nordling J, et al., Bladder pain syndrome committee of the international consultation on incontinence. Neurourol Urodyn 2010; 29: 191-8.
6. Haylen BT, de Ridder D, Freeman RM, et al., An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29: 4-20.
7. Kuo HC,. Videourodynamic study for diagnosis of bladder outlet obstruction in women. J Formos Med Assoc 2000; 99: 386-92.
8. Abrams P, Cardoza L, Fall M, et al., The stardardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78. (Pubitemid 34195211)
9. Parsons CL, Greenberger M, Gabal L, Bidair M, Barme G,. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998; 159: 1862-6.
10. Nixon A, Colman S, Sabounjian L, et al., A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 2005; 174: 604-7. (Pubitemid 40981612)
11. Gillenwater Jr, Wein AJ,. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diaseases Workshop on Interstitial Cystitis. Besthesda, MD: National Institute of Health, Aug 28-29, 1987. J Urol 1987; 140: 203-6.
12. Parsons CL,. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 2007; 69: 9-16.
13. Homma Y, Ueda T, Tomoe H, et al., Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol 2009; 16: 597-615.
14. Liu HT, Kuo HC,. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 2007; 70: 463-8.
15. Kuo HC,. Urodynamic study and potassium sensitivity test for women with frequency urgency syndrome and interstitial cystitis. Urol Int 2003; 71: 61-5.
16. Gupta SK, Pidcock L, Parr NJ,. The potassium sensitivity test: a predictor of treatment response in interstitial cystitis. BJU Int 2005; 96: 1063-6. (Pubitemid 41531415)
17. Kahn BS, Tatro C, Parsons CL, Willems JJ,. Prevalence of interstitial cystitis in vulvodynia patients detected by bladder potassium sensitivity. J Sex Med 2010; 7 (2 Pt 2): 996-1002.
18. Shie JH, Kuo HC,. Higher level of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome. BJU Int 2011; 108 (2 Pt 2): E136-41.
19. Chung SD, Liu HT, Lin H, Kuo HC,. Elevation of serum C-reactive protein in patients with OAB and IC/PBS implies chronic inflammation in the urinary bladder. Neurourol Urodynam 2011; 30: 417-20.
20. Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pfuger H,. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis. Eur Urol 2005; 47: 393-7. (Pubitemid 40248868)
21. Chung MK, Butrick CW, Chung CW,. The overlap of interstitial cystitis/painful bladder syndrome and overactive bladder. JSLS 2010; 14: 83-90.
22. Kuo HC,. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Urology 2005; 66: 1005-9.